-
Carbapenemase Gene Transfer in CREC
2026-08-20
A 2025 BMC Microbiology study combined plasmid elimination, PCR, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The study found frequent blaNDM-1 carriage and a high observed transfer rate of carbapenemase-encoding genes, emphasizing the value of tracking both resistance phenotypes and genetic mobility in antimicrobial resistance research.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-20
The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose catabolism. Its findings connect nuclear RNA processing with interferon-γ production and antitumor immunity, while showing that this metabolic program is distinct from canonical CD28–PI3K signaling.
-
Isoprenaline Hydrochloride in Heart–Brain Models
2026-08-19
Learn how Isoprenaline Hydrochloride, also known as isoproterenol, can connect β-adrenergic stimulation with cardiac, vascular, and neurobehavioral readouts. This practical guide covers preparation, assay design, reference-backed parameters, heart–brain workflows, and troubleshooting.
-
Metoprolol BA2737: Reliable Cell Assay Design
2026-08-19
Learn how Metoprolol (SKU BA2737) can be integrated into cell viability, proliferation, and cytotoxicity workflows without confusing pharmacology with assay artefact. This scenario-based guide covers controls, preparation, interpretation, storage, and practical vendor selection.
-
BFH772 (VEGFR2 inhibitor): Practical Guide
2026-08-18
BFH772 is a selective VEGFR2 kinase inhibitor for experiments that require controlled modulation of VEGFR2-mediated angiogenic signaling and compatibility with organic solvents. It is not appropriate for workflows requiring a water-soluble preparation, broad-spectrum kinase inhibition, or direct extrapolation from biochemical potency to cellular or clinical dosing.
-
Angiotensin I: RAS Precursor for Research
2026-08-18
Angiotensin I is a defined decapeptide and the immediate substrate-derived precursor of angiotensin II in the classical renin-angiotensin system. A1006 supports controlled ACE-conversion experiments, cardiovascular disease mechanisms, and antihypertensive drug screening when peptide identity, handling, and assay controls are explicit.
-
Carvedilol Phosphate in GPCR Assay Design
2026-08-17
Carvedilol Phosphate can help researchers separate beta-adrenergic, alpha-1, and cell-interaction effects in advanced GPCR and ischemia–reperfusion assays. This guide translates Arrb2–6-ketoLCA findings into a rigorous experimental design framework rather than presenting the compound as an established hepatic IRI treatment.
-
Epinephrine Bitartrate: Research Workflows
2026-08-17
Epinephrine Bitartrate gives researchers a practical way to probe broad α- and β-adrenergic signaling in cell, tissue, and translational studies. This workflow-focused guide combines concentration-response design, route-comparison logic, and troubleshooting for more reproducible cardiovascular, airway, immune, and sympathetic nervous system experiments.
-
Isoprenaline Hydrochloride in Heart–Brain Assays
2026-08-16
Isoprenaline Hydrochloride, also known as isoproterenol, enables controlled β-adrenergic stimulation for cardiac and heart–brain research. This guide focuses on assay interpretation, causal controls, and translating sympathetic cardiac activation into robust neurocardiac experimental designs.
-
BAY-826 Workflow for Retinal Signaling Research
2026-08-15
BAY-826 offers a nanomolar chemical-perturbation strategy for testing angiopoietin-linked signaling in Müller cell and retinal neuron models. This workflow pairs co-culture, hypoxia, PEDF, and Tie-2/PI3K/Akt readouts with practical controls that help distinguish pathway effects from solvent toxicity or nonspecific loss of viability.
-
ACE2 Activation in Sepsis-Induced Cardiomyopathy
2026-08-14
The reference study identifies ACE2 downregulation as a feature of sepsis-induced cardiac injury and shows that pharmacological ACE2 activation with diminazene aceturate improves cardiac and cellular outcomes in a murine cecal ligation and puncture model. Its central contribution is connecting ACE2–Mas receptor signaling with Sirt1-dependent mitochondrial biogenesis, while the findings remain preclinical and require validation beyond pharmacological intervention.
-
ICAA Targets RIP3 in Angiotensin II Cardiac Hypertrophy
2026-08-14
A 2026 Cellular Signalling study identifies isochlorogenic acid A (ICAA) as a direct regulator of RIP3 and shows that it suppresses angiotensin II- and pressure overload-induced cardiac hypertrophy through the RIP3/CaMKII axis. The work separates this hypertrophic mechanism from canonical RIP3/MLKL necroptosis and provides a preclinical framework for studying maladaptive cardiac remodeling.
-
O6-Benzylguanine: Designing Better MGMT Assays
2026-08-13
O6-Benzylguanine is a mechanistically precise MGMT inhibitor for studying DNA repair inhibition and sensitization to alkylating agents. This guide connects suicide-substrate pharmacology with recent AP-2α–MGMT findings to help researchers design more informative cancer chemotherapy assays.
-
3D Cardiac Organoid Mapping with Shell MEAs
2026-08-13
The reference study introduces shape-adaptive shell microelectrode arrays that wrap cardiac organoids and record electrical activity across three dimensions. By combining customizable electrode layouts, conduction mapping, calcium imaging, and pharmacological challenges including E-4031, the platform expands cardiac electrophysiology research beyond the planar limits of conventional MEAs.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-08-12
Build reproducible translation, delivery, viability, and imaging assays around a Cap1- and poly(A)-optimized firefly luciferase transcript. The workflow also shows how the reference study’s adaptive nanocoacervates could be evaluated as a cytosolic delivery strategy without confusing uptake with productive protein expression.